U.S. Stock News

NYSE:BDX
NYSE:BDXMedical Equipment

Becton Dickinson Wellstar Alliance Tests AI Hospital Medication Platform Narrative

Becton Dickinson (NYSE:BDX) has entered into a partnership with Wellstar Health System to deploy AI-powered medication management and infusion technologies. The collaboration centers on BD Pyxis Pro medication dispensing and BD Alaris infusion systems, applied across Wellstar’s facilities. The relationship also includes joint work on future product development focused on connected care and digital capabilities. Becton Dickinson earns a large share of its revenue from medical technologies...
NYSE:CSTM
NYSE:CSTMMetals and Mining

Is It Too Late To Consider Constellium (CSTM) After Its Recent Share Price Surge

If you are wondering whether Constellium at around US$32.87 is still attractively priced or if much of the potential upside has already been realized, this article walks through what the current price might be implying. The stock has recently shown strong price moves, with returns of 5.1% over 7 days, 21.2% over 30 days, 66.3% year to date and 193.7% over the last year. These moves have come as Constellium continues to attract attention in the materials sector, with investors reacting to its...
NYSE:SBR
NYSE:SBROil and Gas

Sabine Royalty Trust (SBR) Margins Near 95% Challenge Bearish Royalty Decline Narratives

Sabine Royalty Trust (SBR) just wrapped up FY 2025 with fourth quarter revenue of US$13.7 million and basic EPS of US$0.87, alongside trailing twelve month revenue of US$77.5 million and EPS of US$5.04. Over recent periods, revenue has ranged from US$19.5 million in Q1 2025 to US$25.7 million in Q3 2025, with EPS moving between US$1.22 and US$1.70, while trailing net profit margins have stayed above 94%. For income focused investors, these results highlight a business where very high margins...
NasdaqGM:NAMS
NasdaqGM:NAMSBiotechs

NewAmsterdam Pharma (NAMS) Valuation Check After Earnings Beat And Obicetrapib Pipeline Milestones

NewAmsterdam Pharma (NAMS) drew fresh attention after reporting first quarter 2026 results that came in ahead of revenue and earnings estimates, while management highlighted several upcoming clinical and regulatory milestones. See our latest analysis for NewAmsterdam Pharma. The stock reacted sharply to the update, with a 1 day share price return of 12.46% and a 7 day share price return of 22.02%. This comes even though the year to date share price return is slightly negative, while the 1...
NYSE:FUN
NYSE:FUNHospitality

Six Flags Leadership Shakeup Meets Strong Valuation And Momentum Signals

Six Flags Entertainment (NYSE:FUN) has announced several senior leadership changes, including a new Chief Marketing Officer from Carnival Cruise Line. The company has appointed a new Chief Legal and Compliance Officer joining from Dentons. An Interim Chief Financial Officer has stepped in following the resignation of the previous CFO. These appointments come as Six Flags Entertainment trades around $22.76, with recent moves in the stock that include a 21.2% return over the past week and...
NasdaqCM:BTDR
NasdaqCM:BTDRSoftware

Why Bitdeer Technologies Group (BTDR) Is Up 22.6% After Surging AI Cloud Demand And Bitcoin Output

In the past week, Bitdeer Technologies Group reported accelerating demand from AI customers, lifting its cloud business to about US$43.00 million in annual recurring revenue, while also self-mining 661 Bitcoins in March, a very large year-on-year increase linked to higher hash rate. This combination of growing AI-related cloud revenues and sharply higher self-mined Bitcoin output highlights how Bitdeer is leaning on both computing and crypto operations to scale its business model ahead of...
NasdaqGS:OTEX
NasdaqGS:OTEXSoftware

Open Text (OTEX) Valuation Check After Profit Jump Cloud Momentum And New CEO Appointment

Open Text (OTEX) is back in focus after its latest fiscal third quarter, where profit roughly doubled on modest revenue growth, supported by recurring cloud and support revenues and a new chief executive stepping in. See our latest analysis for Open Text. The stock has reacted sharply to the earnings and CEO news, with a 1 month share price return of 18.56% and a 7 day gain of 6.55%. However, the 1 year total shareholder return of a 5.54% decline and the 5 year total shareholder return of a...
NYSE:DAL
NYSE:DALAirlines

Delta Air Lines Gains Edge As Spirit Collapse Reshapes Fares And Costs

Spirit Airlines has entered liquidation, removing a major ultra-low-cost competitor from the U.S. market. The shakeout is altering fare and capacity dynamics across the industry, with NYSE:DAL positioned as a key beneficiary. At the same time, geopolitical conflict is contributing to higher jet fuel prices, pressuring airline cost structures. Delta is leaning into its premium-focused model, while adjusting capacity and costs to support profitability in a volatile operating environment. For...
NasdaqGM:ATAI
NasdaqGM:ATAIPharmaceuticals

How Positive Phase 2a Data For EMP-01 In Social Anxiety Disorder At AtaiBeckley (ATAI) Has Changed Its Investment Story

AtaiBeckley recently reported positive Phase 2a results for EMP-01, an oral R-MDMA therapy for Social Anxiety Disorder, showing meaningful symptom reductions and good tolerability after a two-dose regimen without psychotherapy. The company’s plan to advance EMP-01 as a scalable outpatient treatment could be particularly important in broadening access to care for social anxiety patients. Next, we’ll examine how EMP-01’s encouraging efficacy and safety profile in Social Anxiety Disorder shapes...
NasdaqGS:QS
NasdaqGS:QSAuto Components

Assessing QuantumScape (QS) Valuation As Eagle Line Launch And First Customer Billings Mark Commercial Progress

QuantumScape (QS) is back in focus after a cluster of milestones, including the start up of its Eagle Line pilot solid state cell facility and the company’s first customer billings and ecosystem partner revenues. See our latest analysis for QuantumScape. Recent milestones around Eagle Line, early ecosystem billings and a push into AI data center power and defense have come alongside choppy trading, with a 1-day share price return of a 7.41% decline, a 30-day share price return of 18.53% and a...
NYSE:CNH
NYSE:CNHMachinery

How Investors Are Reacting To CNH (CNH) Profit Slump Amid Steady Sales and New Dividend Approval

CNH Industrial’s first-quarter 2026 results showed broadly flat sales and revenue at about US$3.17 billion and US$3.83 billion, but net income fell to US$7 million from US$131 million a year earlier, sharply reducing earnings per share. A week later, shareholders approved the 2025 financial statements, re-appointed the board, and authorized a cash dividend, underscoring CNH Industrial’s commitment to capital returns and sustainability reporting even as profitability weakened. We’ll now...
NasdaqGS:GTM
NasdaqGS:GTMInteractive Media and Services

A Look At ZoomInfo Technologies (GTM) Valuation After Barclays And Stifel Cut Targets But Reaffirm Ratings

Analysts at Barclays and Stifel recently reaffirmed their existing ratings on ZoomInfo Technologies (GTM), while trimming forward expectations in response to softer sector sentiment and company specific guidance comments. See our latest analysis for ZoomInfo Technologies. At a share price of US$6.62, ZoomInfo has seen a 14.14% 30 day share price return and a 5.92% 7 day share price return, but this recent momentum sits against a 31.11% year to date share price decline and a 28.36% 1 year...
NYSE:CON
NYSE:CONHealthcare

A Look At Concentra Group Holdings Parent (CON) Valuation After Raised 2026 Guidance And Q1 Earnings Beat

Why Concentra Group Holdings Parent Stock Is Back in Focus Concentra Group Holdings Parent (CON) is back on investors radar after Q1 2026 earnings topped market estimates, full year guidance was raised, and management highlighted continued expansion and acquisition integration. See our latest analysis for Concentra Group Holdings Parent. The stock has gained momentum around these updates, with a 1-day share price return of 3.42% and a 30-day share price return of 10.64%. The 1-year total...
NYSE:SMA
NYSE:SMASpecialized REITs

Assessing SmartStop Self Storage REIT (SMA) Valuation After Recent Share Price Momentum

Recent performance snapshot SmartStop Self Storage REIT (SMA) has attracted fresh attention after a recent move in the stock, with shares closing at $33.48 and showing positive returns over the past week and month. For investors tracking shorter term momentum, the stock shows a 4.3% return over 1 day, 6.4% over 7 days, about 10.7% over the past month and 4.4% over the past 3 months, while the 1 year total return stands near a 2.4% decline. See our latest analysis for SmartStop Self Storage...
NYSE:ELV
NYSE:ELVHealthcare

A Look At Elevance Health (ELV) Valuation After Its Q1 2026 Earnings Beat And Guidance Raise

Elevance Health (ELV) is back in focus after its Q1 2026 earnings topped revenue and adjusted EPS expectations. The company also lifted full year EPS guidance and highlighted firm medical cost control. See our latest analysis for Elevance Health. The Q1 beat and higher guidance arrive after a sharp 19.6% 1 month share price return and a 10% 3 month share price return. However, the 1 year total shareholder return of a 7.6% decline and 3 year total shareholder return of a 14.3% decline indicate...
NYSE:FNF
NYSE:FNFInsurance

A Look At Fidelity National Financial (FNF) Valuation After Q1 2026 Earnings Miss

Fidelity National Financial (FNF) drew fresh attention after Q1 2026 earnings and revenue came in below market expectations, even though reported sales and profit figures showed year on year growth and highlighted margin resilience. See our latest analysis for Fidelity National Financial. FNF’s share price reaction around the Q1 2026 miss has been soft, with a 1-day share price return of a 2% decline and a 7-day return of a 3.9% decline. However, a 30-day share price return of 8% and a 3-year...
NYSE:DT
NYSE:DTSoftware

Dynatrace (DT) Is Up 11.5% After Starboard Pushes Margin Gains And Buybacks - What's Changed

In late April 2026, activist investor Starboard Value revealed a significant stake in Dynatrace, Inc. and publicly urged the company to expand margins, accelerate share repurchases, and consider all options to enhance shareholder value. This push coincides with optimistic earnings expectations and fresh third-party recognition of Dynatrace’s AI-driven observability platform, sharpening investor focus on how operational decisions could reshape its long‑term growth and profitability...
NYSE:BX
NYSE:BXCapital Markets

Assessing Blackstone (BX) Valuation As AI Data Center And Biotech Bets Expand

AI data centers and biotech: what Blackstone’s latest moves mean for the stock Blackstone (BX) has put fresh capital to work on two fronts, sponsoring the IPO of Blackstone Digital Infrastructure Trust to own AI focused data centers, and committing $250 million to Anagram Therapeutics for an enzyme replacement therapy. See our latest analysis for Blackstone. At a share price of $122.33, Blackstone has a 30 day share price return of 8.52% but a year to date share price decline of 22.97%. Its 5...
NYSE:BLD
NYSE:BLDConsumer Durables

A Look At TopBuild (BLD) Valuation After Recent Share Price Swings And Merger Focus

TopBuild (BLD) has drawn investor attention after recent trading left the stock with mixed short term returns, including a decline over the past week and gains over the past month. See our latest analysis for TopBuild. That recent 3.3% 7 day share price decline and 2.5% 1 day move come after a strong 22.0% 1 month share price return, alongside a 47.1% 1 year total shareholder return. This points to momentum that has cooled in the very short term but remains strong over a longer horizon. If...
NYSEAM:UEC
NYSEAM:UECOil and Gas

A Look At Uranium Energy (UEC) Valuation As Burke Hollow Becomes First New US ISR Uranium Mine In Over A Decade

Uranium Energy (UEC) is back in focus after securing regulatory approval and starting production at its Burke Hollow project, which is the first new U.S. in situ recovery uranium mine in more than a decade. See our latest analysis for Uranium Energy. The Burke Hollow approval and production start come as the stock trades at $15.16, with a 30-day share price return of 12.05% and year-to-date share price return of 15.64%. The 1-year total shareholder return of 165.96% and very large 3-year...
NYSE:EMR
NYSE:EMRElectrical

What Emerson Electric (EMR)'s Earnings Beat, Guidance Hike and Tech-Savvy Board Pick Mean For Shareholders

In early May 2026, Emerson Electric Co. reported second-quarter sales of US$4,562 million and net income of US$618 million, modestly higher than a year earlier, affirmed its quarterly dividend of US$0.555 per share, issued new sales and EPS guidance for the third quarter and full year, and announced the upcoming board appointment of Apple General Counsel Jennifer Newstead. The combination of slightly stronger earnings, updated growth and profit guidance, and the addition of a seasoned...
NasdaqGS:EXTR
NasdaqGS:EXTRCommunications

A Look At Extreme Networks (EXTR) Valuation After New Wi Fi 7 And AI Platform Launches

Extreme Networks (EXTR) has put new product launches at the center of its story, with fresh Wi-Fi 7 hardware, its Extreme Agent ONE AI platform, and a flagship collegiate stadium deployment capturing market attention. See our latest analysis for Extreme Networks. These launches come after a period of strong momentum in the stock, with a 30 day share price return of 48.67% and a 1 year total shareholder return of 58.70%, indicating sustained investor interest around Extreme Connect...
NYSE:FIGS
NYSE:FIGSLuxury

Is It Too Late To Consider FIGS (FIGS) After A 204% One Year Rally?

Investors may be wondering whether FIGS stock still offers value after its strong run, or if most of the easy upside is already reflected in the price. FIGS shares recently closed at US$15.37, with returns of 2.7% over 7 days, 13.9% over 30 days, 34.9% year to date and 204.4% over the past year. This naturally raises questions about how the risk and reward now stack up. Recent news coverage has focused on FIGS as a high growth healthcare apparel stock and on how investors are reassessing the...
NYSE:ICL
NYSE:ICLChemicals

ICL Group (ICL) Valuation Check After New Water Soluble Fertiliser Plant Opens In India

ICL Group (ICL) has opened a new water soluble fertiliser plant in Supa, Maharashtra, India, a move tied to food security efforts and geopolitically strained fertiliser supply chains. See our latest analysis for ICL Group. Investors have recently rewarded ICL Group's expansion moves, with a 1-day share price return of 6.76% adding to a 30-day share price return of 12.36%. However, the 1-year total shareholder return is 10.24% lower, suggesting momentum has picked up in the short term. If this...